Cargando…

Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications

Epigenetic aberrations are recognized as having pivotal roles in cancer etiology and progression. Histone deacetylases are among the most studied epigenetic modulators in various cancer types. The expression levels of class I histone deacetylase isoforms 1, 2, and 3 in patient-derived primary osteos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaiyawat, Parunya, Pruksakorn, Dumnoensun, Phanphaisarn, Areerak, Teeyakasem, Pimpisa, Klangjorhor, Jeerawan, Settakorn, Jongkolnee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811636/ https://www.ncbi.nlm.nih.gov/pubmed/28984297 http://dx.doi.org/10.1038/modpathol.2017.125

Ejemplares similares

Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2019)

Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2017)

IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2021)

Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2020)

Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2017)

Safety and efficacy of intralesional steroid injection for aggressive fibromatosis
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2017)

Exploring targeted therapy of osteosarcoma using proteomics data
por: Chaiyawat, Parunya, et al.
Publicado: (2017)

Surgical outcomes of extracorporeal irradiation and re-implantation in extremities for high grade osteosarcoma: A retrospective cohort study and a systematic review of the literature
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2018)

Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2016)

Osteosarcoma-Specific Genes as a Diagnostic Tool and Clinical Predictor of Tumor Progression
por: Sittiju, Pattaralawan, et al.
Publicado: (2022)

Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway
por: Chaiyawat, Parunya, et al.
Publicado: (2019)

Descriptive epidemiology of soft tissue sarcomas and gastrointestinal stromal tumors in Thailand
por: Klangjorhor, Jeerawan, et al.
Publicado: (2022)

Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial
por: Koonrungsesomboon, Nut, et al.
Publicado: (2020)

Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review
por: Orrapin, Santhasiri, et al.
Publicado: (2022)

Hyaluronan production and chondrogenic properties of primary human chondrocyte on gelatin based hematostatic spongostan scaffold
por: Klangjorhor, Jeerawan, et al.
Publicado: (2012)

Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction
por: Sirikaew, Nutnicha, et al.
Publicado: (2022)

Recurrent tibial intra-cortical osteosarcoma: a case report and review of the literature
por: Arpornchayanon, Olarn, et al.
Publicado: (2011)

Ankle ligament reconstruction after wide resection of the osteosarcoma of the distal fibula: a case report
por: Vaseenon, Tanawat, et al.
Publicado: (2017)

The Survival Outcomes, Prognostic Factors and Adverse Events following Systemic Chemotherapy Treatment in Bone Sarcomas: A Retrospective Observational Study from the Experience of the Cancer Referral Center in Northern Thailand
por: Sirikul, Wachiranun, et al.
Publicado: (2023)

Comparison of growth factor adsorbed scaffold and conventional scaffold with growth factor supplemented media for primary human articular chondrocyte 3D culture
por: Klangjorhor, Jeerawan, et al.
Publicado: (2014)

Spindle Cell Hemangioma of the Midfoot: A Case Report
por: Vaseenon, Tanawat, et al.
Publicado: (2017)

Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma
por: Moonmuang, Sutpirat, et al.
Publicado: (2021)

Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)
por: Phinyo, Phichayut, et al.
Publicado: (2020)

Correction: Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)
por: Phinyo, Phichayut, et al.
Publicado: (2022)

Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer
por: Orrapin, Santhasiri, et al.
Publicado: (2023)

The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer
por: Moonmuang, Sutpirat, et al.
Publicado: (2023)

Genomics-Driven Precision Medicine in Pediatric Solid Tumors
por: Suthapot, Praewa, et al.
Publicado: (2023)

Prospective evaluation of serum biomarker levels and cartilage repair by autologous chondrocyte transplantation and subchondral drilling in a canine model
por: Nganvongpanit, Korakot, et al.
Publicado: (2009)

Natural disease progression and novel survival prediction model for hepatocellular carcinoma with spinal metastases: a 10-year single-center study
por: Phinyo, Phichayut, et al.
Publicado: (2020)

Validation of a Diagnostic Model to Differentiate Multiple Myeloma from Bone Metastasis
por: Phinyo, Phichayut, et al.
Publicado: (2023)

Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma
por: Torres, Haydee M., et al.
Publicado: (2021)

Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy
por: Blattmann, Claudia, et al.
Publicado: (2015)

Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
por: Moreno-Yruela, Carlos, et al.
Publicado: (2022)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Transcription Regulation by Class III Histone Deacetylases (HDACs)—Sirtuins
por: Dai, Yan, et al.
Publicado: (2008)

Eloquent silence: developmental functions of Class I histone deacetylases
por: Cunliffe, Vincent T
Publicado: (2008)

Class IIa Histone Deacetylases Are Conserved Regulators of Circadian Function
por: Fogg, Paul C. M., et al.
Publicado: (2014)

A Class 1 Histone Deacetylase with Potential as an Antifungal Target
por: Bauer, Ingo, et al.
Publicado: (2016)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma
por: Yang, Qiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kse16jnip8nfgn1nskihs62jrd